Find Research Outputs

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Author

  • John C Jr. Burnett
2018

Relaxing With C-Type Natriuretic Peptide, the Guanylyl Cyclase B Receptor, and Pericytes

Sangaralingham, S. J. & Burnett, J. C. J., Jul 31 2018, In : Circulation. 138, 5, p. 509-512 4 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2011

Controlling the flood gates: Vaptans, furosemide and the quest for a renal protective diuresis

Costello-Boerrigter, L. C. & Burnett, J. C., Dec 2011, In : Journal of Cardiac Failure. 17, 12, p. 990-992 3 p.

Research output: Contribution to journalEditorial

1 Scopus citations
2012

M-atrial natriuretic peptide: A novel antihypertensive protein therapy

McKie, P. M., Ichiki, T. & Burnett, J. C., Feb 1 2012, In : Current Hypertension Reports. 14, 1, p. 62-69 8 p.

Research output: Contribution to journalArticle

18 Scopus citations
2013
10 Scopus citations
2015

Urinary C-type natriuretic peptide: An emerging biomarker for heart failure and renal remodeling

Zakeri, R., Burnett, J. C. & Sangaralingham, S. J., Mar 1 2015, In : Clinica Chimica Acta. 443, p. 108-113 6 p.

Research output: Contribution to journalReview article

14 Scopus citations
2011

Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial

Blair, J. E. A., Pang, P. S., Schrier, R. W., Metra, M., Traver, B., Cook, T., Campia, U., Ambrosy, A., Burnett, J. C., Grinfeld, L., Maggioni, A. P., Swedberg, K., Udelson, J. E., Zannad, F., Konstam, M. A. & Gheorghiade, M., Oct 1 2011, In : European heart journal. 32, 20, p. 2563-2572 10 p.

Research output: Contribution to journalArticle

88 Scopus citations
2017

Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling

Ichiki, T., Huntley, B. K., Harty, G. J., Sangaralingham, S. J. & Burnett, J. C. J., May 1 2017, In : Physiological Reports. 5, 9, e13283.

Research output: Contribution to journalArticle

3 Scopus citations
2018

Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review

Oatmen, K. E., Zile, M. R., Burnett, J. C. J. & Spinale, F. G., Jan 1 2018, (Accepted/In press) In : JAMA Cardiology.

Research output: Contribution to journalArticle

1 Scopus citations
2014

PTH: Potential role in management of heart failure

Gruson, D., Buglioni, A. & Burnett, J. C., Jun 10 2014, In : Clinica Chimica Acta. 433, p. 290-296 7 p.

Research output: Contribution to journalReview article

23 Scopus citations
2013

BNP Molecular Forms and Processing by the Cardiac Serine Protease Corin

Ichiki, T., Huntley, B. K. & Burnett, J. C., 2013, Advances in Clinical Chemistry. Academic Press Inc, p. 1-31 31 p. (Advances in Clinical Chemistry; vol. 61).

Research output: Chapter in Book/Report/Conference proceedingChapter

30 Scopus citations
2019

Atrial natriuretic peptide: A molecular target of novel therapeutic approaches to cardio-metabolic disease

Cannone, V., Cabassi, A., Volpi, R. & Burnett, J. C. J., Jul 1 2019, In : International journal of molecular sciences. 20, 13, 3265.

Research output: Contribution to journalReview article

Open Access
2 Scopus citations
2014

In vitro evaluation of cenderitide-eluting stent I - An antirestenosis and proendothelization approach

Ng, X. W., Huang, Y., Liu, K. L., Lim, S. G., Chen, H. H., Burnett, J. C., Boey, Y. C. F. & Venkatraman, S. S., Sep 15 2014, In : Journal of Pharmaceutical Sciences. 103, 11, p. 3631-3640 10 p.

Research output: Contribution to journalArticle

3 Scopus citations
2013

Cenderitide-Eluting Film for Potential Cardiac Patch Applications

Ng, X. W., Huang, Y., Chen, H. H., Burnett, J. C., Boey, F. Y. C. & Venkatraman, S. S., Jul 4 2013, In : PloS one. 8, 7, e68346.

Research output: Contribution to journalArticle

9 Scopus citations
2011

Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type i receptor, in healthy and heart failure canines: A novel therapeutic strategy for acute heart failure

Boerrigter, G., Lark, M. W., Whalen, E. J., Soergel, D. G., Violin, J. D. & Burnett, J. C., Nov 1 2011, In : Circulation: Heart Failure. 4, 6, p. 770-778 9 p.

Research output: Contribution to journalArticle

105 Scopus citations
2013

GPCR biased ligands as novel heart failure therapeutics

Violin, J. D., Soergel, D. G., Boerrigter, G., Burnett, J. C. & Lark, M. W., Oct 1 2013, In : Trends in cardiovascular medicine. 23, 7, p. 242-249 8 p.

Research output: Contribution to journalReview article

30 Scopus citations
2011

Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: Analysis from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) Trials

Pang, P. S., Gheorghiade, M., Dihu, J., Swedberg, K., Khan, S., Maggioni, A. P., Grinfeld, L., Zannad, F., Burnett, J. C., Ouyang, J., Udelson, J. E. & Konstam, M. A., Jun 1 2011, In : American Heart Journal. 161, 6, p. 1067-1072 6 p.

Research output: Contribution to journalArticle

32 Scopus citations
2012

Natriuretic peptide infusion reduces myocardial injury during acute ischemia/reperfusion

Kousholt, B. S., Larsen, J. K. R., Bisgaard, L., Burnett, J. C., Hasenkam, J. M. & Goetze, J. P., Mar 2012, In : Cardiovascular Endocrinology. 1, 1, p. 4-12 9 p.

Research output: Contribution to journalArticle

5 Scopus citations
2014

Natriuretic peptides in cardiovascular diseases: Current use and perspectives

Volpe, M., Rubattu, S. & Burnett, J., Feb 1 2014, In : European heart journal. 35, 7, p. 419-425c

Research output: Contribution to journalReview article

126 Scopus citations
2013

Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: A 9-year follow-up study

Cannone, V., Huntley, B. K., Olson, T. M., Heublein, D. M., Scott, C. G., Bailey, K. R., Redfield, M. M., Rodeheffer, R. J. & Burnett, J. C., Nov 1 2013, In : Hypertension. 62, 5, p. 860-865 6 p.

Research output: Contribution to journalArticle

33 Scopus citations
2011

A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community

Cannone, V., Boerrigter, G., Cataliotti, A., Costello-Boerrigter, L. C., Olson, T. M., McKie, P. M., Heublein, D. M., Lahr, B. D., Bailey, K. R., Averna, M., Redfield, M. M., Rodeheffer, R. J. & Burnett, J. C., Aug 2 2011, In : Journal of the American College of Cardiology. 58, 6, p. 629-636 8 p.

Research output: Contribution to journalArticle

64 Scopus citations
2013

Secretion of prohormone of b-type natriuretic peptide, proBNP1-108: Is increased in heart failure

Costello-Boerrigter, L. C., Lapp, H., Boerrigter, G., Lerman, A., Bufe, A., Macheret, F., Heublein, D. M., Larue, C. & Burnett, J. C., Jun 1 2013, In : JACC: Heart Failure. 1, 3, p. 207-212 6 p.

Research output: Contribution to journalArticle

18 Scopus citations
2020

Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF)

Udelson, J. E., Lewis, G. D., Shah, S. J., Zile, M. R., Redfield, M. M., Burnett, J., Mittleman, R. S., Profy, A. T., Seferovic, J. P., Reasner, D. & Konstam, M. A., Apr 2020, In : American heart journal. 222, p. 183-190 8 p.

Research output: Contribution to journalArticle

1 Scopus citations
2015

Weight loss, saline loading, and the natriuretic peptide system

Arora, P., Reingold, J., Baggish, A., Guanaga, D. P., Wu, C., Ghorbani, A., Song, Y., Chen-Tournaux, A., Khan, A. M., Tainsh, L. T., Buys, E. S., Williams, J. S., Heublein, D. M., Burnett, J. C., Semigran, M. J., Bloch, K. D., Scherrer-Crosbie, M., Newton-Cheh, C., Kaplan, L. M. & Wang, T. J., Jan 16 2015, In : Journal of the American Heart Association. 4, 1, p. e001265

Research output: Contribution to journalArticle

18 Scopus citations
2016

Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure

McKie, P., Schirger, J. A., Benike, S. L., Harstad, L. K., Slusser, J. P., Hodge, D. O., Redfield, M. M., Burnett, J. C. J. & Chen, H. H., 2016, (Accepted/In press) In : European Journal of Heart Failure.

Research output: Contribution to journalArticle

17 Scopus citations

Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure

Andersen, I. A., Huntley, B. K., Sandberg, S. S., Heublein, D. M. & Burnett, J. C. J., May 1 2016, In : Nephrology Dialysis Transplantation. 31, 5, p. 767-772 6 p.

Research output: Contribution to journalArticle

22 Scopus citations
2020

Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC: Heart Failure Position Paper

Ibrahim, N. E., Burnett, J. C., Butler, J., Camacho, A., Felker, G. M., Fiuzat, M., O'Connor, C., Solomon, S. D., Vaduganathan, M., Zile, M. R. & Januzzi, J. L., May 2020, In : JACC: Heart Failure. 8, 5, p. 347-358 12 p.

Research output: Contribution to journalReview article

2012

Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: A kidney-heart connection

Martin, F. L., McKie, P. M., Cataliotti, A., Jeson Sangaralingham, S., Korinek, J., Huntley, B. K., Oehler, E. A., Harders, G. E., Ichiki, T., Mangiafico, S., Nath, K. A., Redfield, M. M., Chen, H. H. & Burnett, J. C., Jan 1 2012, In : American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 302, 2, p. R292-R299

Research output: Contribution to journalArticle

52 Scopus citations
2013
29 Scopus citations
2012

A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: Analysis from the EVEREST trial

Gheorghiade, M., Pang, P. S., Ambrosy, A. P., Lan, G., Schmidt, P., Filippatos, G., Konstam, M., Swedberg, K., Cook, T., Traver, B., Maggioni, A., Burnett, J., Grinfeld, L., Udelson, J. & Zannad, F., May 1 2012, In : Heart Failure Reviews. 17, 3, p. 485-509 25 p.

Research output: Contribution to journalArticle

81 Scopus citations
2011
15 Scopus citations
2013

The atrial natriuretic peptide genetic ariant rs5068 is associated with a favorable cardiometabolic phenotype in a mediterranean population

Cannone, V., Cefalu, A. B., Noto, D., Scott, C. G., Bailey, K. R., Cavera, G., Pagano, M., Sapienza, M., Averna, M. R. & Burnett, J. C., Sep 1 2013, In : Diabetes care. 36, 9, p. 2850-2856 7 p.

Research output: Contribution to journalArticle

31 Scopus citations
2017

Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis)

Gupta, D. K., Daniels, L. B., Cheng, S., deFilippi, C. R., Criqui, M. H., Maisel, A. S., Lima, J. A., Bahrami, H., Greenland, P., Cushman, M., Tracy, R., Siscovick, D., Bertoni, A. G., Cannone, V., Burnett, J. C., Carr, J. J. & Wang, T. J., Sep 15 2017, In : American Journal of Cardiology. 120, 6, p. 1008-1015 8 p.

Research output: Contribution to journalArticle

21 Scopus citations
2016

Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation

Grupper, A., Zhao, Y. M., Sajgalik, P., Joyce, L. D., Park, S. J., Pereira, N. L., Stulak, J. M., Burnett, J. C. J., Edwards, B. S., Daly, R. C., Kushwaha, S. S. & Schirger, J. A., Jan 18 2016, (Accepted/In press) In : American Journal of Cardiology.

Research output: Contribution to journalArticle

7 Scopus citations
2017

Experimental cardiac radiation exposure induces ventricular diastolic dysfunction with preserved ejection fraction

Saiki, H., Moulay, G., Guenzel, A. J., Liu, W., Decklever, T. D., Classic, K. L., Pham, L., Chen, H. H., Burnett, J. C., Russell, S. J. & Redfield, M. M., Aug 11 2017, In : American Journal of Physiology - Heart and Circulatory Physiology. 313, 2, p. H392-H407

Research output: Contribution to journalArticle

13 Scopus citations
2011

The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic peptide

Sangaralingham, S. J., Huntley, B. K., Martin, F. L., McKie, P. M., Bellavia, D., Ichiki, T., Harders, G. E., Chen, H. H. & Burnett, J. C., Feb 1 2011, In : Hypertension. 57, 2, p. 201-207 7 p.

Research output: Contribution to journalArticle

64 Scopus citations
2013

Renin-angiotensin blockade combined with natriuretic peptide system augmentation novel therapeutic concepts to combat heart failure

Von Lueder, T. G., Sangaralingham, S. J., Wang, B. H., Kompa, A. R., Atar, D., Burnett, J. C. & Krum, H., May 1 2013, In : Circulation: Heart Failure. 6, 3, p. 594-605 12 p.

Research output: Contribution to journalArticle

92 Scopus citations

The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction.

Greene, S. J., Gheorghiade, M., Borlaug, B. A., Pieske, B., Vaduganathan, M., Burnett, J. C., Roessig, L., Stasch, J. P., Solomon, S. D., Paulus, W. J. & Butler, J., 2013, In : Journal of the American Heart Association. 2, 6, p. e000536

Research output: Contribution to journalReview article

Open Access
53 Scopus citations
2015

Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: Biomarkers or mediators

Buglioni, A. & Burnett, J. C., Mar 1 2015, In : Clinica Chimica Acta. 443, p. 3-8 6 p.

Research output: Contribution to journalArticle

16 Scopus citations
2011

Designer natriuretic peptides: A vision for the future of heart failure therapeutics

Zakeri, R. & Burnett, J. C., Aug 1 2011, In : Canadian Journal of Physiology and Pharmacology. 89, 8, p. 593-601 9 p.

Research output: Contribution to journalArticle

19 Scopus citations
2013

Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with Tolvaptan

Hauptman, P. J., Burnett, J., Gheorghiade, M., Grinfeld, L., Konstam, M. A., Kostic, D., Krasa, H. B., Maggioni, A., Ouyang, J., Swedberg, K., Zannad, F., Zimmer, C. & Udelson, J. E., Jun 1 2013, In : Journal of Cardiac Failure. 19, 6, p. 390-397 8 p.

Research output: Contribution to journalArticle

90 Scopus citations
2011

Corin is present in the normal human heart, kidney, and blood, with Pro-B-type natriuretic peptide processing in the circulation

Ichiki, T., Huntley, B. K., Heublein, D. M., Sandberg, S. M., McKie, P. M., Martin, F. L., Jougasaki, M. & Burnett, J. C., Jan 1 2011, In : Clinical chemistry. 57, 1, p. 40-47 8 p.

Research output: Contribution to journalArticle

70 Scopus citations
2019

Discovery of O-glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor

Hansen, L. H., Madsen, T. D., Goth, C. K., Clausen, H., Chen, Y., Dzhoyashvili, N., Iyer, S. R., Sangaralingham, S. J., Burnett, J. C., Rehfeld, J. F., Vakhrushev, S. Y., Schjoldager, K. T. & Goetze, J. P., Aug 23 2019, In : Journal of Biological Chemistry. 294, 34, p. 12567-12578 12 p.

Research output: Contribution to journalReview article

Open Access
5 Scopus citations

CRRl269: A novel particulate guanylyl cyclase a receptor peptide activator for acute kidney injury

Chen, Y., Harty, G. J., Zheng, Y., Iyer, S. R., Sugihara, S., Sangaralingham, S. J., Ichiki, T., Grande, J. P., Lee, H. C., Wang, X. & Burnett, J. C., May 10 2019, In : Circulation research. 124, 10, p. 1462-1472 11 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations
4 Scopus citations
2017

A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA)

Cannone, V., Scott, C. G., Decker, P. A., Larson, N., Palmas, W., Taylor, K. D., Wang, T. J., Gupta, D. K., Bielinski, S. J. & Burnett, J. C. J., Dec 1 2017, In : PLoS One. 12, 12, e0189858.

Research output: Contribution to journalArticle

6 Scopus citations

BLAST-AHF: Insights into biased AT1 ligands and heart failure. Beginning of the end or end of the beginning?

Sugihara, S. & Burnett, J. C. J., Aug 7 2017, In : European Heart Journal. 38, 30, p. 2374-2376 3 p.

Research output: Contribution to journalReview article

1 Scopus citations
2014

MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure

Puccia, G., Cannone, V., McKie, P. & Burnett, J. C. J., Jul 1 2014, Natriuretic Peptides: Physiology, Molecular Biology, and Clinical Implications. Nova Science Publishers, Inc., p. 77-100 24 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

2016

NT-proBNP: The Gold Standard Biomarker in Heart Failure

McKie, P. & Burnett, J. C. J., Dec 6 2016, In : Journal of the American College of Cardiology. 68, 22, p. 2437-2439 3 p.

Research output: Contribution to journalEditorial

23 Scopus citations
2012

Protein therapeutics for cardiovascular disease: It is all about delivery

Ichiki, T. & Burnett, J. C., Dec 18 2012, In : Journal of the American College of Cardiology. 60, 24, p. 2558-2560 3 p.

Research output: Contribution to journalEditorial

4 Scopus citations
2011

Heart failure: Furosemide-to DOSE or not to DOSE, that is the question

Costello-Boerrigter, L. C. & Burnett, J. C., Jul 1 2011, In : Nature Reviews Cardiology. 8, 7, p. 365-366 2 p.

Research output: Contribution to journalArticle

1 Scopus citations